Presentation: Human primary B lymphocytes for the rapid high throughput discovery of native therapeutic monoclonal antibodies

Developing therapeutic monoclonal antibodies and ADC's is a key focus of the pharmaceutical industry's R&D. The European Antibody Congress 2012 bought together senior level executives and opinion leaders from around the globe to further their knowledge and engage in discussion on a variety of topics relating to mAbs, ADC's and bispecifics. Attendees at this highly successful event were fortunate enough …

Download Presentation: Revisiting the immune regulatory properties of therapeutic antibodies

  Developing therapeutic monoclonal antibodies and ADC's is a key focus of the pharmaceutical industry's R&D. The European Antibody Congress 2012 brought together senior level executives and opinion leaders from around the globe to further their knowledge and engage in discussion on a variety of topics relating to mAbs, ADC's and bispecifics. Attendees at this highly successful event were fortunate …

Roche Pharmaceuticals produce next generation therapeutic antibodies using today’s cell-culture technology

Roche Pharmaceuticals produce next generation therapeutic antibodies using today's cell-culture technology: Are you looking to deliver next generation therapeutic antibodies using existing cell culture technology? Do you want to reduce costs by utilising existing bio-manufacturing methodologies? Find out how this goal was achieved at the Cell Culture World Congress 2012 where Dr Ingo Gorr, Senior Research Scientist Cell Culture Research …